Keyphrases
Neurotoxicity
100%
Neurologic Symptoms
100%
Group Studies
100%
Paclitaxel
100%
Gynecologic Oncology Group
100%
Doxorubicin
33%
Cisplatin
33%
Criterion Validity
33%
Treatment Difference
33%
Clinical Trials
16%
Area under the Receiver Operating Characteristic Curve
16%
Internal Consistency
16%
Longitudinal Change
16%
Construct Validity
16%
Internal Consistency Reliability
16%
Treatment Change
16%
Cronbach's alpha
16%
Subscale Scores
16%
Recurrent Endometrial Cancer
16%
Paclitaxel-induced Peripheral Neuropathy
16%
Medicine and Dentistry
Neurologic Disease
100%
Gynecological Oncology
100%
Paclitaxel
100%
Neurotoxicity
100%
Arm
33%
Doxorubicin
33%
Cisplatin
33%
Neuropathy
16%
Uterine Cancer
16%
Clinical Trial
16%
Nursing and Health Professions
Neurologic Disease
100%
Paclitaxel
100%
Neurotoxicity
100%
Doxil
33%
Cisplatin
33%
Receiver Operating Characteristic
16%
Criterion Related Validity
16%
Endometrium Cancer
16%
Construct Validity
16%
Internal Consistency
16%
Neuropathy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neurotoxicity
100%
Neurologic Disease
100%
Paclitaxel
100%
Doxorubicin
33%
Cisplatin
33%
Clinical Trial
16%
Neuropathy
16%
Endometrium Cancer
16%
Neuroscience
Paclitaxel
100%
Neurotoxicity
100%
Cisplatin
33%
Doxorubicin
33%
Neuropathy
16%